Nestlé today inaugurated two new factories in the China Medical City in Taizhou, Jiangsu Province. The factories will meet the needs of consumers for Foods for Special Medical Purposes (FSMP) and skin care products.
This CHF 150 million investment (over 1 billion yuan) for the new factories Nestlé Health Science and Galderma adds to Nestlé’s existing industrial set up and underscores the Company’s confidence in the future prospects of the Chinese market.
The two state-of-the-art factories, built on 13 ha area, utilize best-in-class technologies to ensure high quality assurance to manufacturing efficiency. They will also contribute to the development of the local economies through local production.
Representatives from Jiangsu provincial and Taizhou municipal governments, industry associations and academics joined Mr. Magdi Batato, Executive Vice President, Head of Operations for Nestlé S.A., at the inauguration ceremony.
Magdi Batato: “Nestlé is fully committed to continue to invest to support sustainable growth in China. By bringing the manufacturing capabilities of Nestlé Health Science and Nestlé Skin Health to China, we are in a stronger position to enhance Nestlé’s product offering and meet consumer expectations.”
Nestlé has identified consumer healthcare as an addition growth platform, complementary to its core food and beverage business. The new investment underlines Nestlé’s purpose to enhance quality of life and contribute to healthier future.
Rashid Qureshi, Chairman and CEO of Nestlé Greater China: "These new factories significantly strengthen Nestlé’s product and services offering to serve consumers in China. They underscore Nestlé’s commitment to nutrition, health and wellness, which is fully in line with government’s priority to build a healthier population in China."
Liu Xuecong, secretary-general of the China Nutritional and Health Food Association: "The FSMP industry is expected to become the new blue ocean for China's health industry. Nestlé Taizhou factory is scientifically and technologically advanced and will undoubtedly play an important role in supporting the healthy development of China's FSMP industry.”
Galderma, Nestlé Skin Health’s medical solutions business, was created in 1981 and is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails. The portfolio includes brand such as Restylane, Cetaphil, Loceryl, Facile, Proactiv, etc. For more information, please visit www.galderma.com.